Andrew Huberman· PhD
In any case, this compound increases GLP-1. It's actually a GLP-1 analog in some cases, and they go by various types of trade names.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
In any case, this compound increases GLP-1. It's actually a GLP-1 analog in some cases, and they go by various types of trade names.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Originally they were only used as anti-diabetic drugs and then the what was considered kind of an offtarget effect of controlling satiety is now the mechanism of action at these much higher doses as the dose has been multiplied up to the kind of current WGO weight loss dose.